995 resultados para Energy meters


Relevância:

30.00% 30.00%

Publicador:

Resumo:

Energy efficient policies are being applied to network protocols, devices and classical network management systems. Researchers have already studied in depth each of those fields, including for instance a long monitoring processes of various number of individual ICT equipment from where power models are constructed. With the development of smart meters and emerging protocols such as SNMP and NETCONF, currently there is an open field to couple the power models, translated to the expected behavior, with the realtime energy measurements. The goal is to derive a comparison on the power data between both of the processes in the direction of detection for possible deviations on the expected results. The logical assumption is that a fault in the usage of a particular device will not only increase its own energy usage, but also may cause additional consumption on the other devices part of the network. A platform is developed to monitor and analyze the retrieved power data of a simulated enterprise ICT infrastructure. Moreover, smart algorithms are developed which are aware of the different states that are occurring on each device during their typical use phase, as well as to detect and isolate possible anomalies. The produced results are obtained and validated with the use of Cisco switches and routers, Dell Precision stations and Raritan PDU as part of the monitored infrastructure.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

This paper proposes a method for scheduling tariff time periods for electricity consumers. Europe will see a broader use of modern smart meters for electricity at residential consumers which must be used for enabling demand response. A heuristic-based method for tariff time period scheduling and pricing is proposed which considers different consumer groups with parameters studied a priori, taking advantage of demand response potential for each group and the fairness of electricity pricing for all consumers. This tool was applied to the case of Portugal, considering the actual network and generation costs, specific consumption profiles and overall electricity low voltage demand diagram. The proposed method achieves valid results. Its use will provide justification for the setting of tariff time periods by energy regulators, network operators and suppliers. It is also useful to estimate the consumer and electric sector benefits from changes in tariff time periods.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

OBJECTIVE: To compare, in patients with cancer and in healthy subjects, measured resting energy expenditure (REE) from traditional indirect calorimetry to a new portable device (MedGem) and predicted REE. DESIGN: Cross-sectional clinical validation study. SETTING: Private radiation oncology centre, Brisbane, Australia. SUBJECTS: Cancer patients (n = 18) and healthy subjects (n = 17) aged 37-86 y, with body mass indices ranging from 18 to 42 kg/m(2). INTERVENTIONS: Oxygen consumption (VO(2)) and REE were measured by VMax229 (VM) and MedGem (MG) indirect calorimeters in random order after a 12-h fast and 30-min rest. REE was also calculated from the MG without adjustment for nitrogen excretion (MGN) and estimated from Harris-Benedict prediction equations. Data were analysed using the Bland and Altman approach, based on a clinically acceptable difference between methods of 5%. RESULTS: The mean bias (MGN-VM) was 10% and limits of agreement were -42 to 21% for cancer patients; mean bias -5% with limits of -45 to 35% for healthy subjects. Less than half of the cancer patients (n = 7, 46.7%) and only a third (n = 5, 33.3%) of healthy subjects had measured REE by MGN within clinically acceptable limits of VM. Predicted REE showed a mean bias (HB-VM) of -5% for cancer patients and 4% for healthy subjects, with limits of agreement of -30 to 20% and -27 to 34%, respectively. CONCLUSIONS: Limits of agreement for the MG and Harris Benedict equations compared to traditional indirect calorimetry were similar but wide, indicating poor clinical accuracy for determining the REE of individual cancer patients and healthy subjects.